$ 1.15
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Undervalued vs peers
About
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers,...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers.
Target Price
The average target price of TLRY is 0.91 and suggests 21% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to dec
